Citation: | ZOU Yu-qiong, ZHANG Ying-ying, LI Ya-song. Study on the clinical significance of bone metabolism types in young adult patients with ankylosing spondylitis[J]. Chinese Journal of General Practice, 2021, 19(9): 1463-1465,1603. doi: 10.16766/j.cnki.issn.1674-4152.002086 |
[1] |
胡劲涛, 柴乐, 任伟凡, 等. 强直性脊柱炎骨代谢的研究进展[J]. 中国骨质疏松杂志, 2019, 25(6): 875-879. doi: 10.3969/j.issn.1006-7108.2019.06.031
|
[2] |
MAGREY M N, LEWIS S, ASIM KHAN M, et al. Utility of DX-A scanning and risk factors for osteoporosis in ankylosing spondylitis-A prospective study[J]. Semin Arthritis Rheum, 2016, 46(1): 88-94. doi: 10.1016/j.semarthrit.2016.03.003
|
[3] |
WANG D M, ZENG Q Y, CHEN S B, et al. Prevalence and risk factors of osteoporosis in patients with ankylosing spondylitis: A 5-year follow-up study of 504 cases[J]. Clin Exp Rheumatol, 2015, 33(4): 465-470. http://www.ncbi.nlm.nih.gov/pubmed/25962324
|
[4] |
钟驾云, 吴歆, 徐沪济. 强直性脊柱炎合并骨质疏松或骨量减少临床研究进展[J]. 诊断学理论与实践, 2019, 18(1): 1109-1112. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDLS201901038.htm
|
[5] |
YOON B H, YU W. Clinical utility of biochemical marker of bone turnover: Fracture risk prediction and bone healing[J]. J Bone Metab, 2018, 25(2): 73-78. doi: 10.11005/jbm.2018.25.2.73
|
[6] |
ARCEO-MENDOZA R M, CAMACHO P. Prediction of fracture risk in patients with osteoporosis: a brief review[J]. Womens Health(Lond), 2015, 11(4): 477-484. http://www.onacademic.com/detail/journal_1000038319582410_1e44.html
|
[7] |
边平达, 寿张轩, 李秀央, 等. 骨转换标志物在高龄男性骨密度变化中的预测价值[J]. 中华骨质疏松和骨矿盐疾病杂志, 2018, 11(2): 155-159. https://www.cnki.com.cn/Article/CJFDTOTAL-GUSS201802010.htm
|
[8] |
张萌萌, 张秀珍, 邓伟民, 等. 骨代谢生化指标临床应用专家共识(2019)[J]. 中国骨质疏松杂志, 2019, 25(10): 1357-1372. doi: 10.3969/j.issn.1006-7108.2019.10.001
|
[9] |
刘胜峰, 金玮, 杜玉珍. 上海临港地区健康人群骨代谢标志物β-CTx和tP1NP参考区间的建立[J]. 检验医学与临床, 2018, 15(20): 3121-3124. doi: 10.3969/j.issn.1672-9455.2018.20.037
|
[10] |
陈德才, 廖二元, 徐苓骨, 等. 骨代谢生化标志物临床应用指南[J]. 中华骨质疏松和骨矿盐疾病杂志, 2015, 8(4): 283-293. doi: 10.3969/j.issn.1674-2591.2015.04.001
|
[11] |
范晓云, 李志军. 强直性脊柱炎的诊断与治疗[J]. 中华全科医学, 2020, 18(8): 1256-1257. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202008002.htm
|
[12] |
MALOCHET-GUINAMAND S, PEREIRA B, TATAR Z, et al. Preva-lence and risk factors of low bone mineral density in spondyloarthritis and prevalence of vertebral fractures[J]. BMC Musculoskelet Disord, 2017, 18(1): 357. doi: 10.1186/s12891-017-1718-7
|
[13] |
MAAS F, SPOORENBERG A, VAN DER SLIK B P G, et al. Clinical risk factors for the presence and development of vertebral fractures in patients with ankylosing spondylitis[J]. Arthritis Care Res(Hoboken), 2017, 69(5): 694-702. doi: 10.1002/acr.22980
|
[14] |
HENRIKSEN K, CHRISTIANSEN C, KARSDAL M A. Role of biochemical markers in the management of osteoporosis[J]. Climacteric, 2015, 18(Suppl 2): 10-18.
|
[15] |
KOBAVASHI Y, UEHARA S, UDAGAWA N. Roles of non-canonical Wnt signaling pathways in bone resorption[J]. J Oral Biosci, 2018, 60(2): 31-35. doi: 10.1016/j.job.2018.03.001
|
[16] |
王晓林, 曾凡伟, 陈芳. 强直性脊柱炎发生脊柱骨折的危险因素及与骨代谢指标相关性分析[J]. 实用医院临床杂志, 2020, 17(3): 218-221. https://www.cnki.com.cn/Article/CJFDTOTAL-YYLC202003065.htm
|
[17] |
LIU K G, HE Q H, TAN J W, et al. Expression of TNF-alpha, VEGF, and MMP-3 mRNAs in synovial tissues and their roles in fibroblast-mediated osteogenesis in ankylosing spondylitis[J]. Genet Mol Res, 2015, 14(2): 6852-6858. doi: 10.4238/2015.June.18.28
|
[18] |
YANG C, DING P, WANG Q, et al. Inhibition of complement retards ankylosing spondylitis progression[J]. Sci Rep, 2016, 6: 34643. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048143/pdf/srep34643.pdf
|